Navigation Links
Forest Laboratories Announces Resignation of Ivan Gergel, MD
Date:3/19/2008

NEW YORK, March 19 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX) today announced that Ivan Gergel, MD, Senior Vice President - Scientific Affairs and President of the Forest Research Institute has resigned his position and will leave the Company effective March 31, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20001011/FORESTLOGO )

Lawrence Olanoff, MD, PhD, President and Chief Operating Officer of Forest, stated: "The Board and I wish to thank Ivan Gergel for his ten years of service at Forest. His contributions are appreciated and have been especially significant for our CNS products, such as Celexa, Lexapro and Namenda. We wish him well in his future endeavors."

The Company is currently in the process of identifying a potential successor. In the interim the Forest Research Institute will continue to be overseen by Dr. Olanoff.

About Forest Laboratories Inc. and Its Products

Forest Laboratories (http://www.frx.com) is a U.S.-based pharmaceutical company dedicated to identifying, developing, and delivering products that make a positive difference in peoples' lives. Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment of major depressive disorder and generalized anxiety disorder; Namenda(R) (memantine HCl), an N-methyl D-aspartate (NMDA)-receptor antagonist indicated for the treatment of moderate to severe Alzheimer's disease; Campral(R)* (acamprosate calcium), indicated in combination with psychosocial support for the maintenance of abstinence from alco
'/>"/>

SOURCE Forest Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Lake Forest Hospital Proposes a New Health Care System in Lake County
2. Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Lawsuits Against Several Companies for Patent Infringement
3. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Third Quarter Earnings
4. Abbott Donates Cool Globe to Lake County Forest Preserves for Permanent Display at Greenbelt Cultural Center
5. Forest Laboratories and Cypress Bioscience to Host Webcast to Discuss Clinical Data Presentations for Milnacipran
6. Parasites a key to the decline of red colobus monkeys in forest fragments
7. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Second Quarter Earnings
8. Out of the woods: Physicians get urban disaster training in forests, gorges and waters
9. Dr. Wei Sun, PhD, MD Joins SpectraCell Laboratories
10. Stiefel Laboratories, Inc. Appoints New President
11. Mylan Announces Appointment of Jagdish Dore as CEO and Managing Director of Matrix Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Doheny HealthDay Reporter , , THURSDAY, May 23 (HealthDay ... dropping sharply, especially among Hispanic teens, according to a new ... aged 15 to 19 dropped by nearly one half from ... 1,000 teens to 31 births for every 1,000. From ... fell 25 percent, from 41.5 to about 31. During ...
(Date:5/23/2013)... at Emory Vaccine Center have shown that an immune ... responses in mice against viral infections. , The results ... , "Our findings highlight how IL-21 could be important ... Ata Ur Rasheed Mohammed, PhD, the first author of ... director of the Emory Vaccine Center and a Georgia ...
(Date:5/23/2013)... OAK BROOK, Ill. (May 23, 2013) Aortic arch ... a strong independent predictor of disease of the vessels ... new study published in the June issue the journal ... the aortic arch provides functional information about vessel compliance ... disease down the road," said Kevin S. King, M.D., ...
(Date:5/23/2013)... 23, 2013 During pregnancy both the ... affected by medical treatments, especially medication. In July ... of Medicine prompted the FDA to warn about a ... defects such as persistent pulmonary hypertension and other malformations ... reuptake inhibitor (SSRI) drugs. SSRI antidepressants are widely ...
(Date:5/23/2013)... Maintaining its commitment to improving life through better ... off in the spirit of Better Sleep Month, DUXIANA ... and to providing a therapeutic sleep experience, helping to ... Better Sleep Month, a result of the call to ... the Centers for Disease Control’s confirmation that insufficient sleep ...
Breaking Medicine News(10 mins):Health News:U.S. Teen Birth Rate Plummets: Report 2Health News:U.S. Teen Birth Rate Plummets: Report 3Health News:Vaccine blackjack: IL-21 critical to fight against viral infections 2Health News:MRI-based measurement helps predict vascular disease in the brain 2Health News:Personal Injury Law Firm Releases Graphic with the Latest Information on Antidepressants and a Possible Risk of Birth Defects 2Health News:Personal Injury Law Firm Releases Graphic with the Latest Information on Antidepressants and a Possible Risk of Birth Defects 3Health News:DUXIANA®, Quality Bed Innovator, Celebrates Better Sleep Month and Launches Summer Health Campaign 2
... from UK show that proteins secreted by eggs of the ... the next anti-inflammatory therapy // . ,Their study ... Experimental Medicine. ,Schistosoma mansoni, a trematode parasite that ... the host to tolerate chronic worm infections, often for decades, ...
... many different forms of cancer. Smoking is linked to many ... For example, 1/3rd of all bladder cancers are caused due ... the scientific community to sensitize individuals to the ill effects ... ,A new study conducted on cancer patients has ...
... been widely talked about and largely accepted. In the same ... there is a 15% reduction in the risk of heart ... of three months. , ,The sample size was 212 ... disease were put to eat a Mediterranean diet for three ...
... having IVF treatment subject themselves to more risks and complications ... fertilization (IVF) has been very successful in women who are ... the procedure a donated egg and a sperm is fertilized ... the womb of a woman. The egg can sometimes be ...
... due to Peanut allergy after her boyfriend kissed her after ... city of Saguenay, though she received a dose of adrenaline ... the hypersensitivity reaction and died a week after the kiss. ... an autopsy has been planned for Christina Desforges. , ...
... The Scientific Advisory Committee for Nutrition in United Kingdom ... acid/Vitamin B12.// , Folic acid acts as an ... women has it protects newborn babies from birth defects. ... people as they are prone to B12 deficiency leading ...
Cached Medicine News:Health News:Most Smokers Continue To Smoke Despite Developing Cancer 2Health News:Complication More in Women Having IVF Treatment 2
(Date:5/23/2013)... Calif. , May 23, 2013 More ... cancer may not benefit from chemotherapy and still have ... the launch of one of the largest sources of ... new website and interactive Facebook page provide recently diagnosed ... they can safely avoid chemotherapy. "We anticipate ...
(Date:5/23/2013)... May 23, 2013  Every day, their baby stopped breathing, ... his lungs. April and Bryan Gionfriddo ... true. "Quite a few doctors said he had ... April Gionfriddo , about her now 20-month-old ... would work, we would take it and run with it." ...
(Date:5/23/2013)... 23, 2013  Spring Bank Pharmaceuticals, Inc., a biopharmaceutical ... infections, today announced that it has initiated dosing in ... once daily, oral therapy for the treatment of HCV ... and is designed to assess both the safety and ... first-in-class drug for the treatment of chronic HCV infections ...
Breaking Medicine Technology:Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3
... in Blood Glucose,Control and Progressive Weight Loss ... Amylin,Pharmaceuticals, Inc. and Eli Lilly and Company ... BYETTA(R) (exenatide) injection,sustained improvements in blood sugar ... a half years of therapy. BYETTA treatment,was ...
... --,Phosphagenics Limited (AIM: PSG) announced today positive results,from ... formulated with retinoic acid, a leading topical,treatment for ... cosmetics. , The proof of concept studies showed ... delivered into the skin when formulated,with TPM-02 compared ...
Cached Medicine Technology:Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 2Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 3Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 4Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 5Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 6Phosphagenics Announces Positive Proof of Concept Results from,Studies Utilizing Company's Dermal Drug Delivery Technology 2
A rapid, convenient, qualitative method for detecting asymptomatic occult bleeding....
... The use of guaiac as a test ... the oxidation of phenolic compounds present in guaiac ... blue color. If blood is present, the heme ... a pseudoenzymatic manner, catalyzing the release of oxygen ...
... The Original MaybeMom™ Mini ... medical diagnostic instument which uses ... her personal menstrual/fertility cycle, including ... ovulation and menstruation to increase ...
... only test designed specifically for detecting ... pH. It includes a convenient pH ... range which is important in monitoring ... can now spend less time testing ...
Medicine Products: